Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects

References

• Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr.. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89:299 - 304; http://dx.doi.org/10.1016/S1079-2104(00)70092-8; PMID: 10710453
   PubMed Web of Science ®Google Scholar
• Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357:1411 - 2; http://dx.doi.org/10.1016/S0140-6736(00)04578-5; PMID: 11356441
   PubMed Web of Science ®Google Scholar
• Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92:623 - 8; http://dx.doi.org/10.1067/moe.2001.118902; PMID: 11740479
   PubMed Web of Science ®Google Scholar
• Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul P, Nilmanat A, et al. Effects of long-term use of HAART on oral health status of HIV-infected subjects. J Oral Pathol Med 2010; 39:397 - 406; http://dx.doi.org/10.1111/j.1600-0714.2009.00826.x; PMID: 20202089
   PubMed Web of Science ®Google Scholar
• Yohannes E, Ghosh SK, Jiang B, McCormick TS, Weinberg A, Hill E, et al. Proteomic signatures of human oral epithelial cells in HIV-infected subjects. PLoS One 2011; 6:e27816; http://dx.doi.org/10.1371/journal.pone.0027816; PMID: 22114700
   PubMedGoogle Scholar
• Scully C, Diz Dios P. Orofacial effects of antiretroviral therapies. Oral Dis 2001; 7:205 - 10; http://dx.doi.org/10.1034/j.1601-0825.2001.70401.x; PMID: 11575869
   PubMed Web of Science ®Google Scholar
• Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006; 19:57 - 62; http://dx.doi.org/10.1177/154407370601900112; PMID: 16672551
   PubMedGoogle Scholar
• Goodgame JC, Pottage JC Jr., Jablonowski H, Hardy WD, Stein A, Fischl M, et al. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team. Antivir Ther 2000; 5:215 - 25; PMID: 11075942
   PubMed Web of Science ®Google Scholar
• Roca B. Adverse drug reactions to antiretroviral medication. Front Biosci 2009; 14:1785 - 92; http://dx.doi.org/10.2741/3340; PMID: 19273162
   PubMed Web of Science ®Google Scholar
• Danaher RJ, Wang C, Roland AT, Kaetzel CS, Greenberg RN, Miller CS. HIV protease inhibitors block oral epithelial cell DNA synthesis. Arch Oral Biol 2010; 55:95 - 100; http://dx.doi.org/10.1016/j.archoralbio.2009.12.001; PMID: 20035926
   PubMed Web of Science ®Google Scholar
• Chow WA, Jiang C, Guan M. Anti-HIV drugs for cancer therapeutics: back to the future?. Lancet Oncol 2009; 10:61 - 71; http://dx.doi.org/10.1016/S1470-2045(08)70334-6; PMID: 19111246
   PubMed Web of Science ®Google Scholar
• Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, et al. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 2007; 13:5183 - 94; http://dx.doi.org/10.1158/1078-0432.CCR-07-0161; PMID: 17785575
   PubMed Web of Science ®Google Scholar
• Jiang W, Mikochik PJ, Ra JH, Lei H, Flaherty KT, Winkler JD, et al. HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest. Cancer Res 2007; 67:1221 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-06-3377; PMID: 17283158
   PubMed Web of Science ®Google Scholar
• Pyrko P, Kardosh A, Wang W, Xiong W, Schönthal AH, Chen TC. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res 2007; 67:10920 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-07-0796; PMID: 18006837
   PubMed Web of Science ®Google Scholar
• Jiang YH, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genomics Hum Genet 2004; 5:479 - 510; http://dx.doi.org/10.1146/annurev.genom.5.061903.180014; PMID: 15485357
   PubMed Web of Science ®Google Scholar
• Nakamura N, Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 1998; 16:471 - 9; http://dx.doi.org/10.1023/A:1006589626307; PMID: 10091942
   PubMed Web of Science ®Google Scholar
• Shahbazian MD, Zoghbi HY. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol 2001; 14:171 - 6; http://dx.doi.org/10.1097/00019052-200104000-00006; PMID: 11262731
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 2003; 163:1911 - 9; http://dx.doi.org/10.1016/S0002-9440(10)63549-3; PMID: 14578190
   PubMed Web of Science ®Google Scholar
• Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the synuclein γ gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 2003; 63:664 - 73; PMID: 12566312
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597 - 610; http://dx.doi.org/10.1038/nrg1655; PMID: 16136652
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148 - 59; http://dx.doi.org/10.1056/NEJMra072067; PMID: 18337604
   PubMed Web of Science ®Google Scholar
• Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8:1056 - 72; http://dx.doi.org/10.1016/S1474-4422(09)70262-5; PMID: 19833297
   PubMed Web of Science ®Google Scholar
• Paschos K, Allday MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol 2010; 18:439 - 47; http://dx.doi.org/10.1016/j.tim.2010.07.003; PMID: 20724161
   PubMed Web of Science ®Google Scholar
• Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses 2009; 73:770 - 80; http://dx.doi.org/10.1016/j.mehy.2008.10.039; PMID: 19501473
   PubMed Web of Science ®Google Scholar
• Choi SW, Friso S. Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr 2010; 1:8 - 16; http://dx.doi.org/10.3945/an.110.1004; PMID: 22043447
   PubMed Web of Science ®Google Scholar
• Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74:481 - 514; http://dx.doi.org/10.1146/annurev.biochem.74.010904.153721; PMID: 15952895
   PubMed Web of Science ®Google Scholar
• Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008; 9:465 - 76; http://dx.doi.org/10.1038/nrg2341; PMID: 18463664
   PubMed Web of Science ®Google Scholar
• Morales V, Richard-Foy H. Role of histone N-terminal tails and their acetylation in nucleosome dynamics. Mol Cell Biol 2000; 20:7230 - 7; http://dx.doi.org/10.1128/MCB.20.19.7230-7237.2000; PMID: 10982840
   PubMed Web of Science ®Google Scholar
• Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 1998; 20:615 - 26; http://dx.doi.org/10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; PMID: 9780836
   PubMed Web of Science ®Google Scholar
• Imai K, Ochiai K. Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression. J Oral Sci 2011; 53:1 - 13; http://dx.doi.org/10.2334/josnusd.53.1; PMID: 21467809
   PubMedGoogle Scholar
• Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 1997; 94:448 - 52; http://dx.doi.org/10.1073/pnas.94.2.448; PMID: 9012803
   PubMed Web of Science ®Google Scholar
• Park JI, Strock CJ, Ball DW, Nelkin BD. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003; 23:543 - 54; http://dx.doi.org/10.1128/MCB.23.2.543-554.2003; PMID: 12509453
   PubMed Web of Science ®Google Scholar
• Hu PP, Shen X, Huang D, Liu Y, Counter C, Wang XF. The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J Biol Chem 1999; 274:35381 - 7; http://dx.doi.org/10.1074/jbc.274.50.35381; PMID: 10585406
   PubMed Web of Science ®Google Scholar
• Doi TS, Takahashi T, Taguchi O, Azuma T, Obata Y. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med 1997; 185:953 - 61; http://dx.doi.org/10.1084/jem.185.5.953; PMID: 9120401
   PubMed Web of Science ®Google Scholar
• Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 1995; 9:1965 - 77; http://dx.doi.org/10.1101/gad.9.16.1965; PMID: 7649478
   PubMed Web of Science ®Google Scholar
• Glaser KB, Li J, Staver MJ, Wei RQ, Albert DH, Davidsen SK. Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun 2003; 310:529 - 36; http://dx.doi.org/10.1016/j.bbrc.2003.09.043; PMID: 14521942
   PubMed Web of Science ®Google Scholar
• Walsh CP, Bestor TH. Cytosine methylation and mammalian development. Genes Dev 1999; 13:26 - 34; http://dx.doi.org/10.1101/gad.13.1.26; PMID: 9887097
   PubMed Web of Science ®Google Scholar
• Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293:1089 - 93; http://dx.doi.org/10.1126/science.1063443; PMID: 11498579
   PubMed Web of Science ®Google Scholar
• Zilberman D, Gehring M, Tran RK, Ballinger T, Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat Genet 2007; 39:61 - 9; http://dx.doi.org/10.1038/ng1929; PMID: 17128275
   PubMed Web of Science ®Google Scholar
• Panning B, Jaenisch R. DNA hypomethylation can activate Xist expression and silence X-linked genes. Genes Dev 1996; 10:1991 - 2002; http://dx.doi.org/10.1101/gad.10.16.1991; PMID: 8769643
   PubMed Web of Science ®Google Scholar
• Chen T, Hevi S, Gay F, Tsujimoto N, He T, Zhang B, et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 2007; 39:391 - 6; http://dx.doi.org/10.1038/ng1982; PMID: 17322882
   PubMed Web of Science ®Google Scholar
• Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, et al. Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. Cell 2001; 104:829 - 38; http://dx.doi.org/10.1016/S0092-8674(01)00280-X; PMID: 11290321
   PubMed Web of Science ®Google Scholar
• Yin L, Chung WO. Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria. Mucosal Immunol 2011; 4:409 - 19; http://dx.doi.org/10.1038/mi.2010.83; PMID: 21248725
   PubMed Web of Science ®Google Scholar
• Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000; 68:2907 - 15; http://dx.doi.org/10.1128/IAI.68.5.2907-2915.2000; PMID: 10768988
   PubMed Web of Science ®Google Scholar
• Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, et al. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem 2010; 285:36523 - 31; http://dx.doi.org/10.1074/jbc.M110.133140; PMID: 20847052
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Gupta S, Jiang B, Weinberg A. Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α. Infect Immun 2011; 79:4578 - 87; http://dx.doi.org/10.1128/IAI.05586-11; PMID: 21911466
   PubMed Web of Science ®Google Scholar
• Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, et al. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 2005; 79:14318 - 29; http://dx.doi.org/10.1128/JVI.79.22.14318-14329.2005; PMID: 16254366
   PubMed Web of Science ®Google Scholar
• Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280:599 - 602; http://dx.doi.org/10.1126/science.280.5363.599; PMID: 9554853
   PubMed Web of Science ®Google Scholar
• Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15:11 - 8; http://dx.doi.org/10.1038/sj.cr.7290257; PMID: 15686620
   PubMed Web of Science ®Google Scholar
• Shetty K, Leigh J.. The Role of human papillomavirus (HPV) and the increasing incidence of oral pathology in the era of highly active antiretroviral therapy (HAART). The Internet Journal of Dental Science 2005; 2:2
   Google Scholar
• Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A. Quantification of human beta-defensin-2 and -3 in body fluids: application for studies of innate immunity. Clin Chem 2007; 53:757 - 65; http://dx.doi.org/10.1373/clinchem.2006.081430; PMID: 17317882
   PubMed Web of Science ®Google Scholar